Stockscreener 앱 받기
1.17
0.00%
0.00
시간 외 거래:
1.17
전일 마감가:
$1.17
열려 있는:
$1.16
하루 거래량:
2.75M
Relative Volume:
0.90
시가총액:
$888.11M
수익:
$606.88M
순이익/손실:
$-225.68M
주가수익비율:
-3.8716
EPS:
-0.3022
순현금흐름:
$-190.82M
1주 성능:
+0.86%
1개월 성능:
-3.31%
6개월 성능:
-19.31%
1년 성능:
-37.10%
1일 변동 폭
$1.15
$1.18
1주일 범위
$1.15
$1.22
52주 변동 폭
$1.11
$1.855
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.17 | 888.11M | 606.88M | -225.68M | -190.82M | -0.3022 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | JP Morgan | Neutral |
| 2025-10-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
OPKO Health (OPK) reports Q4 loss, tops revenue estimates - MSN
Aug Ideas: Is OPKO Health Inc stock forming a cup and handleQuarterly Profit Review & Daily Momentum Trading Reports - baoquankhu1.vn
Opko Health Inc. (OPK) builds value through partnerships and innovation - MSN
Market Moves: Is OPKO Health Inc forming bullish engulfing patternsSwing Trade & Community Trade Idea Sharing Platform - baoquankhu1.vn
Trading Recap: Is OPKO Health Inc likely to announce a buyback2026 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Aug Final Week: Is OPKO Health Inc a strong growth stock2026 Momentum & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Support Test: What is the Moat Score of OPKO Health Inc2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Quarterly Earnings: Will OPKO Health Inc benefit from seasonalityMarket Activity Report & Risk Controlled Daily Plans - baoquankhu1.vn
OPKO Health (NASDAQ:OPK) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Growth Report: Is OPKO Health Inc likely to announce a buybackSwing Trade & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
HC Wainwright Has Weak Forecast for OPKO Health Q4 Earnings - MarketBeat
Opko Health, Inc. (OPK) Stock Analysis: Exploring a 174% Potential Upside Amidst Challenging Fundamentals - DirectorsTalk Interviews
H.C. Wainwright Reaffirms Their Buy Rating on Opko Health (OPK) - The Globe and Mail
OPK PE Ratio & Valuation, Is OPK Overvalued - Intellectia AI
OPKO Health to Participate in Jefferies Biotech Summit - National Today
OPKO Health (NASDAQ:OPK) Given New $1.50 Price Target at Barrington Research - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Q4 2025 Earnings Call Transcript - Insider Monkey
OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - Sahm
OPK Should I Buy - Intellectia AI
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance
OPKO Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - marketscreener.com
OPKO Health Beats Q4 Earnings Estimates - National Today
OPKO Health Q4 Earnings Call Highlights - MarketBeat
OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Announces Earnings Results - MarketBeat
OPKO Health (OPK) Q4 2025 Earnings Call Transcript - The Globe and Mail
OPKO Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: OPKO Health beats Q4 2025 EPS forecast, stock dips - Investing.com
OPKO Health: Q4 Earnings Snapshot - marketscreener.com
OPKO Health Q4 revenue falls - TradingView
Earnings Breakdown: OPKO Health Q4 - Benzinga
OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations - Quiver Quantitative
OPK: Q4 2025 saw lower revenues and a net loss, but strong R&D progress and new partnerships - TradingView
OPKO Health (NASDAQ: OPK) restructures labs, leans on NGENLA and 4Kscore growth - Stock Titan
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results - GlobeNewswire
OPKO Health: Fourth Quarter Financial Overview - Bitget
OPKO Health Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Opko Health, Inc. (OPK) Stock Analysis: A Closer Look At Its 209% Potential Upside - DirectorsTalk Interviews
Revenue Check: Is OPKO Health Inc likely to announce a buyback2025 Performance Recap & Growth Focused Entry Reports - baoquankhu1.vn
Brokerages Set OPKO Health, Inc. (NASDAQ:OPK) Target Price at $2.28 - Defense World
Total debt per share of OPKO Health, Inc. – LSE:0KCS - TradingView
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - The Globe and Mail
OPKO Health (OPK) Projected to Post Quarterly Earnings on Thursday - MarketBeat
MSN Money - MSN
Can OPKO Health's pipeline progress and deals drive growth in 2026? - MSN
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation - Finviz
Opko Health, Inc. (OPK) Investor Outlook: Unpacking The 189.30% Potential Upside - DirectorsTalk Interviews
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Opko Health Inc 주식 (OPK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
0.55%
2.50%
자본화:
|
볼륨(24시간):